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Glycolipids were depleted from medaka embryos 
using 1-phenyl-2-decanoylamino-3-morpholino-l-pro- 
pan01 (PDMP), an inhibitor of glucosylceramide synthe- 
tasc. Embryos cultured in the presence of 20 @fPDMP 
exhibited a dramatic decline in glycolipid synthesis and 
cell surface expression. Metabolic labeling of glucosyl- 
ceramide declined by 87% on Days 3-6 of development 
and 72% on Days 7-10 (hatching occurred on Day 10). 
In parallel, PDMP-treated embryos exhibited a strik- 
ing loss of several tissue-specific glycolipid antigens, 
including Q-O-acetyl GD3 from brain and retina, GT3/ 
GQlC from brain, neural tube, and retina, and sulfated 
glycolipid from skin and gut. Despite these changes in 
glycolipid expression, PDMP-treated embryos were 
fully viable with no evidence of developmental abnor- 
mality. PDMP appears to provide a useful tool for iden- 
tifying glycolipid antigens in embryos and investigating 
their role in development. Q IOSZ Academic PRESS, I~O. 
INTRODUCTION 
Glycolipid expression is known to change rapidly dur- 
ing embryonic development [ 131 and cell differentiation 
[6,1]. These changes may reflect the actions of sequen- 
tial induction signals and serve to facilitate morphoge- 
netic cell interactions. Indeed, there is increasing evi- 
dence that glycolipids, and sphingolipid breakdown 
products regulate a variety of developmental processes, 
including cell proliferation, recognition, and differen- 
tiation (reviewed by Hakomori [9]). 
A pharmacologic agent (PDMP) has been developed 
recently that blocks glycolipid synthesis by competi- 
tively inhibiting UDP-glucose:ceramide fll+glucosyl- 
transferase [ll]. PDMP blocks the formation of gluco- 
sylceramide (CMH) and thus prevents the accumula- 
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tion of complex glycolipids that are derived from CMH 
by oligosaccharide chain elongation (for PDMP struc- 
ture, see Fig. 1). PDMP has been shown previously to 
affect the morphology and glucose transport ability of 
Balb/c 3T3 cells [ 141, the attachment of B16 melanoma 
cells to collagen and laminin [lo], and the mitogenetic 
response of cytotoxic T lymphocyte lines [5]. 
In the present report, we have investigated the effects 
of PDMP on glycolipid synthesis and cell surface ex- 
pression in embryos of a freshwater killifish (medaka). 
Medaka were used for these experiments because, un- 
like mammalian embryos, teleost embryos can be cul- 
tured easily in small volumes of lipid-free medium and 
their entire development can be observed readily under 
a dissecting microscope. Embryos cultured in the pres- 
ence of 5-40 PM PDMP exhibited a striking loss of 
many tissue-specific glycolipid antigens without an ad- 
verse effect on development. 
MATERIALS AND METHODS 
Embryo culture. Medaka (Oryzias htipes) were obtained from a 
breeding colony at the School of Fisheries, University of Washington 
(Seattle, WA). Zygotes were collected within 4 h of ovapositing, 
rinsed with phosphate-buffered saline (PBS), and placed individually 
into the wells of 96-well microtiter plates (Coming) in 200 ~1 of sterile 
Embryo Rearing Medium (Carolina Biological Supply, Burlington, 
NC), in the presence or absence of PDMP. p-threo-PDMP (the active 
enantiomer) was prepared from crystalline powder as a 4 mM stock 
solution in water, filter-sterilized, and stored at 4°C. The culture me- 
dium was changed every 4 days to ensure adequate 0, tension and 
minimize risks of contamination. 
Metabolic labeling. In order to monitor the effects of PDMP on 
glycolipid synthesis, embryos were cultured for 3 days in medium 
(+PDMP) containing D-[6-3H]galactose and D-[6-‘Hlglucosamine 
(ICN, Costa Mesa, CA), with specific activities of 25 and 30 Ci/mmol, 
respectively (used 5 pCi/ml). After labeling, viable embryos were 
washed thoroughly, dried under N2, and extracted with 2 ml of chloro- 
form:methanol (21). The extract was clarified by centrifugation 
(lOOg, 10 min) and the pellet was reextracted twice. Combined ex- 
tracts were desalted on 0.1 ml Cl8 reverse-phase columns (Analytic- 
hem, Harbor City, CA). 
Thin-layer chromatography. Glycolipid samples were streaked 
onto Whatman HP-KF silica-gel plates and subjected to ascending 
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FIG. 3. Effect of PDMP on glycolipid antigen expression. Embryos were cultured in the absence (Control) or presence (PDMP) of 26 fl 
D-threo-PDMP. On the day of hatching (Day lo), fry were transferred to embedding compound and frozen on dry ice. Sections were labeled 
with mAb VESP 6.2 specific for sulfated glycolipids (a-d), mAb ME311 specific for 9-0-acetyl GD3 (e-h), or mAb A2B5 specific for polylsialy- 
lated glycolipids (i-l). Photographs were taken using phase (a, c, e, g, i, k) or fluorescence (b, d, f, h, j, 1) microscopy. Magnification X160 (a-d) 
or X400 (e-l). 
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the case of GD2) may reflect compensatory synthesis of 
a glycolipid structure on a glycoprotein. 
Effects of Glycolipid Depletion on Embryonic 
Development 
Embryos cultured in the absence or presence of 5-40 
PM PDMP appeared to be morphologically identical at 
each stage of development. The time course of hatching 
in control and PDMP-treated groups at three incuba- 
tion temperatures was also similar (Fig. 4). After hatch- 
ing, fry were transferred to 60-mm dishes and main- 
tained in the absence of PDMP for up to 2 weeks. Fry 
that had undergone embryonic development in the pres- 
ence of 20 PM PDMP exhibited normal patterns of be- 
havior, including their ability to swim, feed (both flake 
and live food), respond to bright light, and avoid obsta- 
cles. Thus, PDMP-treated embryos appear to have ac- 
quired normal neurological and visual functions. 
PDMP was nonspecifically toxic to embryos at concen- 
trations above 80 PM. 
DISCUSSION 
The results indicate that medaka embryos can com- 
plete normal development despite a significant reduc- 
tion in cell surface glycolipid. Most notable was the loss 
of several gangliosides from the nervous system and the 
loss of sulfated glycolipid from the skin and gut (Fig. 3). 
These results are surprising because gangliosides such 
as GD3, GT3, and 9-0-acetyl GD3 are characteristic 
markers of neuronal tissues [3, 161 and are believed to 
play an essential role in embryonic development [19]. 
One hypothesis regarding our data is that the small 
amounts of glycolipid that remained after PDMP treat- 
ment (Figs. 2 and 3) were sufficient to maintain the es- 
sential functions of glycolipids in transmembrane sig- 
naling and cell interaction. If so, medaka embryos syn- 
15-c 
thesize more glycolipid than needed for development. In 
this connection, mutant strains of yeast have been iso- 
lated that survive without sphingolipids, albeit with a 
slower growth rate [2]. A second hypothesis is that the 
adaptive value of membrane glycolipids is not appropri- 
ately tested in vitro. For example, glycolipids may serve 
to protect cells in natural environments from patho- 
genic agents, such as viruses, bacteria, and/or extremes 
of temperature; however, in our experiments, the time 
course of hatching in control and PDMP-treated cul- 
tures was identical at both high and low temperatures 
(Fig. 4). A third hypothesis is that embryos employ mul- 
tiple systems to regulate growth, morphogenesis, and 
differentiation. The functions of glycolipid-oligosaccha- 
rides may be shared in large measure by the oligosaccha- 
ride chains of cell surface glycoproteins and proteogly- 
cans. Indeed, protein-bound glycans such as high-molec- 
ular weight lactosaminoglycans may play a more 
important role in mediating cell interactions during 
early development (reviewed by Fenderson et al. [8]). 
In summary, PDMP appears to provide a useful tool 
for studying the glycolipids of cells during development 
and differentiation. For example, PDMP may allow the 
identification of carrier molecules for novel carbohy- 
drate differentiation antigens: carbohydrate antigens 
found exclusively on glycolipids will be lost from cells or 
embryos following PDMP-treatment, whereas carbohy- 
drate antigens found exclusively on glycoproteins will 
remain unaffected. Finally, the results presented here 
identify several glycolipids as neuroectodermal makers 
that should prove useful for future studies of lineage 
formation in medaka embryos. 
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FIG. 4. Effect of PDMP on hatching time. Embryos were cultured in 96-well microtiter plates at 15’C (n = 36 in each group), 2z°C (n = 1s 
in each group), or 30°C (n = 34 in each group). The time course of hatching in control (D) and 20 pM PDMP-treated groups (0) 1s similar. 
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